Top Industry Leaders in the Surgical Equipment Market
Latest Surgical Equipment Companies Update
Oct 2023: On October 26, the India division of Novartis AG, a global pharmaceutical corporation headquartered in Switzerland, declared a scarcity of the immunosuppressive medication "Simulect 20 mg" in India. The pharmaceutical company stated in an exchange filing: "This is to notify that 'Simulect 20 mg,' one of Novartis India Limited's medicines, is now experiencing a shortage. It said, "But the company is making every effort to mitigate the supply issue sustainably." Patients undergoing kidney transplants frequently utilize the intravenous prescription medication Simulect (basiliximab injection). The Novartis medication costs between Rs 67,500 and Rs 68,000 per vial. Transplant patients utilize it to make sure their bodies do not reject
Jan 2023: A definitive agreement was revealed by CONMED Corporation to buy privately held Biorez, Inc. (Biorez) for a cash consideration of $85 million at closing, pending modification, and up to an additional $165 million in growth-based earnout transactions over four years. The acquisition will be completed on a debt-free and cash-free basis. The company's current credit facility is anticipated to be used to finance the acquisition. Based in New Haven, Connecticut, Biorez is a start-up company focused on medical devices that use its patented BioBrace® Implant technology to improve soft tissue healing. The BioBrace implant is a novel bioinductive scaffold designed to promote healing by reinforcing soft tissue in areas of weakness. The FDA has approved BioBrace® for usage in a variety of product sizes.List of Surgical Equipment Key companies in the market
- Medtronic Plc.
- Peters Surgical SASU
- Johnsons & Johnsons
- Conmed Corporation
- Novartis International AG
- Smith & Nephew PLC
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Cousin-Biotech
- Enthral Medical GMBH
- Fuhrmann GMBH
- Integral Lifesciences Holdings Corporation
- KLS Martin Group